- Ginkgo Bioworks to become public today
The biotech is to go public at a valuation of $15 billion. Ginkgo manufactures bacteria with industrial applications and leads the synthetic biology market.
- Investment results for the 2nd quarter of 2021
Pre-IPO market growth, new funding records and 250 new unicorns
- United Traders now available on App Store and Google Play
Download the investment mobile app.
